Safety and Clinical Outcomes of Pembrolizumab Standard-Interval Dosing Versus Extended-Interval Dosing in Patients with Breast Cancer

Zhou M, Velez LM, Kwan D, Moses L, Johnson CD, Nguyen CM, Mott L, Gamie F, Fouladi M, Bae H, Verlande A, Arneson D, Petrus[...]

Cleveland S, Carroll JE, Montoya AK, Cha L, Stiles L, Sumner JA. Early Life Adversity and Mitochondrial Function: Comparing Cumulative Risk and Dimensional Models of[...]

Clair K, Fletcher EH, Oishi A, Schweizer CA, Jackson L, Chanfreau C, Finley EP, Hamilton A, Moin T, Farmer MM, Bean-Mayberry B. "It's Just a[...]